7 Oct 2009 14:24
Immunodiagnostic Systems Holdings plc ("IDS" or '"the Company")
Allotment of shares
Following an exercise of options by an employee, IDS announces that it has today issued and allotted 40,000 ordinary shares of 2p each in the Company ("Ordinary Shares"). Application will be made at the earliest practicable opportunity for admission of the new ordinary shares to trading on the AIM Market of the London Stock Exchange.
Following this allotment, the Company's issued share capital will consist of 26,480,813 Ordinary Shares with voting rights.
Contacts:
| Immunodiagnostic Systems Holdings Plc | Tel: 0191 519 0660 |
| Roger Duggan, CEO | |
| Paul Hailes, Finance Director | |
| Brewin Dolphin Investment Banking | Tel: 0845 213 4730 |
| Andrew Emmott Sean Wyndham-Quin | |
| Walbrook PR Ltd | Tel: 020 7933 8787 |
| Paul McManus | |